Search research articles
Contact Us
Filters
Showing results (161-170 of 172) with videos related to
Page
of 18
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Horticulture Research
|
February 14, 2025
High-quality genome of black wolfberry (<i>Lycium ruthenicum</i> Murr.) provides insights into the genetics of anthocyanin biosynthesis regulation
Yuhui Xu, Haoxia Li, Tongwei Shi, et al.
Journal of Medicinal Chemistry
|
June 23, 2006
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic
Andrew P Combs, Wenyu Zhu, Matthew L Crawley, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
Eddy W Yue, Richard Sparks, Padmaja Polam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach
Colin Zhang, Meizhong Xu, Chunhong He, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies
Niu Shin, Yun-Long Li, Song Mei, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Journal of Medicinal Chemistry
|
October 14, 2005
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics
Andrew P Combs, Eddy W Yue, Michael Bower, et al.
Cancer Biology & Therapy
|
April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Journal of Medicinal Chemistry
|
January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 172) with videos related to
Sort By:
Page
of 18
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Horticulture Research
|
February 14, 2025
High-quality genome of black wolfberry (<i>Lycium ruthenicum</i> Murr.) provides insights into the genetics of anthocyanin biosynthesis regulation
Yuhui Xu, Haoxia Li, Tongwei Shi, et al.
Journal of Medicinal Chemistry
|
June 23, 2006
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic
Andrew P Combs, Wenyu Zhu, Matthew L Crawley, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
Eddy W Yue, Richard Sparks, Padmaja Polam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach
Colin Zhang, Meizhong Xu, Chunhong He, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies
Niu Shin, Yun-Long Li, Song Mei, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Journal of Medicinal Chemistry
|
October 14, 2005
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics
Andrew P Combs, Eddy W Yue, Michael Bower, et al.
Cancer Biology & Therapy
|
April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Journal of Medicinal Chemistry
|
January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Page
of 18